NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure. The New York company said ...

A federal advisory panel unanimously recommended approval Tuesday of a new drug to treat hepatitis B, putting Gilead Sciences on track to launch its second medicine in a year. The U.S. Food & Drug ...

It’s been almost a year since federal regulators approved a new hepatitis C treatment that costs about $1,000 per pill. But time hasn’t done much to ease concerns of state officials who worry about ...

As with other drugs, Vosevi (sofosbuvir/velpatasvir/voxilaprevir) can cause side effects such as headache and diarrhea. If you’re not able to tolerate side effects ...

Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...

TRENTON, N.J. (AP) — An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options — all much more ...

A landmark inquiry investigating the worst treatment disaster in the history of the NHS is set to conclude on Monday. Between the 1970s and early 1990s, patients were given contaminated blood and ...

On World Hepatitis Day today, the spotlight is on one of the most misunderstood but critical public health challenges, viral hepatitis. Observed annually on July 28, this global awareness day focuses ...

The fight over prescription drug costs continues to hurt consumers. — -- For Pamela Anderson, a Hepatitis C diagnosis seemed liked a death sentence. “They said I would die in 10 years,” Anderson ...

PORTLAND, Ore. (KOIN) – A new report from the Centers for Disease Control and Prevention shows Oregon has some of the worst hepatitis C rates in the nation, the Oregon Health Authority announced ...